Back to results
US 2024/0293550 A1Published application
Branched oligonucleotides
AssigneeUniversity of Massachusetts
InventorsAnastasia Khvorova, Matthew Hassler, Julia Alterman, Bruno Miguel da Cruz Godinho
Life of this patent
Estimating the term…
Abstract
Provided herein are branched oligonucleotides exhibiting efficient and specific tissue distribution, cellular uptake, minimum immune response and off-target effects, without formulation.
Claims16
1-44. (canceled)
A di-branched oligonucleotide compound comprising two siRNA molecules covalently bound to one another by way of a linker,
- wherein:
- (a) each siRNA molecule comprises an antisense strand having complementarity to a target gene and a sense strand having complementarity to the antisense strand;
- (b) from 80% to 100% of the nucleotides in each siRNA molecule are chemically modified;
- and
- (c) each antisense strand and each sense strand are, independently, from 15 to 30 nucleotides in length.
2 more elements
Dependencies are inferred from the claim text.